Loading...
Ovulation lasts only 12 to 24 hours, but the fertile window spans about 6 days. Cervical mucus changes, basal body temperature shifts, and ovulation pain are the most evidence-backed signs. Here is what the research says about each one, how reliable they are, and how to use them whether you are trying to conceive or avoid pregnancy.

In reproductive medicine, there is one number that shapes nearly everything: 12 to 24 hours. That is how long an egg survives after ovulation. Miss that window, and conception does not occur, regardless of everything else. The entire enterprise of fertility awareness — cervical mucus tracking, temperature charting, predictor kits, apps — exists to identify those hours with enough lead time to act on them.
The good news is that the body provides real, measurable signals before and during ovulation. The bad news is that these signals vary from woman to woman, cycle to cycle, and are easily confused with other physiological events. I have worked with patients who tracked their cycles with meticulous precision and still missed ovulation, and patients who conceived on their first cycle of trying because they happened to recognize one key symptom. The difference usually comes down to understanding what the signals actually mean, not just knowing they exist.
This guide covers the evidence behind each ovulation sign, how reliable it is, and how to combine multiple indicators for the most accurate picture of your fertile window.
Understanding the signs of ovulation requires understanding what happens physiologically. Ovulation is not a single moment — it is the culmination of a hormonal sequence that begins at the start of the menstrual cycle.
During the follicular phase (days 1 through approximately day 14 in a 28-day cycle), FSH stimulates multiple follicles in the ovaries to develop. By approximately day 7 to 8, one follicle becomes dominant. This dominant follicle produces increasing amounts of estrogen, which does several things: it thickens the uterine lining, changes cervical mucus consistency, and eventually triggers a surge of luteinizing hormone (LH) from the pituitary gland.
The LH surge is the trigger for ovulation. Approximately 24 to 36 hours after the LH surge begins, the dominant follicle ruptures and releases a mature egg into the fallopian tube. The egg is viable for 12 to 24 hours. If sperm are present in the fallopian tube during this time, fertilization can occur.
After ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone. Progesterone causes the post-ovulatory rise in body temperature, prepares the uterine lining for potential implantation, and produces the characteristic symptoms of the luteal phase (the second half of the cycle). If fertilization does not occur, the corpus luteum degenerates after about 12 to 14 days, progesterone drops, and menstruation begins.
The landmark 1995 study by Wilcox and colleagues in the New England Journal of Medicine definitively established the fertile window. Using daily urine samples and ultrasound monitoring in 221 women, they demonstrated that virtually all pregnancies resulted from intercourse during a 6-day window ending on the day of ovulation.
The probability of conception by day relative to ovulation:
| Day relative to ovulation | Probability of conception | Clinical significance |
|---|---|---|
| 5 days before | ~4% | Low but possible (sperm can survive up to 5 days) |
| 4 days before | ~10% | Moderate |
| 3 days before | ~16% | Moderate |
| 2 days before | ~27% | Highest probability day |
| 1 day before | ~31% | Highest probability day |
| Day of ovulation | ~10–15% | Egg already released; time-sensitive |
| 1 day after | ~0% | Egg has typically degenerated |
Two things stand out from this data. First, the most fertile days are the 1 to 2 days before ovulation, not the day of ovulation itself. This is because sperm need time to travel through the reproductive tract and undergo capacitation (a maturation process). Having sperm already in position when the egg is released is more effective than attempting to time intercourse to the exact moment of ovulation.
Second, the window closes rapidly. There is essentially zero probability of conception starting from the day after ovulation. The egg's lifespan is the bottleneck.
Cervical mucus is the single most informative body-based sign of approaching ovulation, and it has the strongest research support for predicting fertility in real time.
A 2004 study by Bigelow and colleagues in Human Reproduction analyzed 2,832 cycles in 674 women and found that the observation of egg-white cervical mucus was a stronger predictor of day-specific probability of conception than any other method, including timing based on cycle day calculations. When egg-white mucus was present, the probability of conception was 2 to 3 times higher than on days with no mucus or sticky mucus, even when controlling for the day relative to ovulation.
The pattern of cervical mucus across the cycle follows a predictable hormonal sequence:
To monitor cervical mucus effectively, check at least twice daily (morning and evening), either by observing what appears on toilet paper when wiping or by collecting mucus from the cervical os with a clean finger. Consistency across multiple checks in a day is more informative than a single observation. Document your observations daily using our ovulation calculator or a dedicated fertility app.
Basal body temperature is your body's resting temperature, measured first thing in the morning before any physical activity. After ovulation, progesterone released by the corpus luteum causes a sustained rise of 0.2°C to 0.5°C (0.4°F to 1.0°F) that persists until the next period.
BBT tracking is a well-validated method for confirming that ovulation has occurred. The rise typically appears 1 to 2 days after ovulation and remains elevated for the duration of the luteal phase (10 to 16 days). If you see a sustained temperature shift (3 or more days of elevated temperatures above the previous 6 days' range — the "3-over-6" rule), ovulation almost certainly occurred.
However, BBT has significant limitations for prospective fertility planning:
Where BBT excels is in pattern recognition over multiple cycles. After 3 to 6 months of tracking, most women can identify their typical ovulation day (the last day of low temperatures before the shift), which helps predict ovulation in future cycles. It is also the most reliable way to confirm anovulatory cycles — if no temperature shift occurs, ovulation likely did not happen that month.
Wearable continuous temperature monitors (Tempdrop, Oura Ring, Ava bracelet) have made BBT tracking less burdensome by measuring temperature automatically during sleep. A 2017 review in Bioengineering & Translational Medicine found that these devices show promising accuracy but are not yet validated to the same standard as traditional morning oral BBT measurement.
Mittelschmerz (German for "middle pain") is a mild to moderate pain or discomfort felt on one side of the lower abdomen around the time of ovulation. It is experienced by approximately 20% of women and can last from a few minutes to 48 hours.
The exact cause is debated. The leading theories include: (1) the swelling of the dominant follicle just before it ruptures, stretching the ovarian capsule; (2) the actual rupture of the follicle; or (3) the release of follicular fluid and a small amount of blood into the peritoneal cavity, which can irritate the peritoneum.
Mittelschmerz can serve as a useful supplementary ovulation sign when combined with other indicators. However, it is not reliable as a sole predictor because:
If you consistently notice one-sided lower abdominal pain mid-cycle, it is a reasonable supplementary data point. Note the day it occurs and compare it to your mucus observations and OPK results over several cycles to see how well it correlates with your actual ovulation day.
Several other physical changes are associated with ovulation, though the evidence for their reliability varies.
Increased libido. Multiple studies have documented a measurable increase in sexual desire in the 2 to 3 days preceding ovulation, correlating with the pre-ovulatory estrogen peak. While this is one of the body's more intuitive fertility signals, it is not specific enough to use as a timing tool — libido is influenced by many factors unrelated to ovulation.
Breast tenderness. Some women notice mild breast tenderness or sensitivity that begins around ovulation and intensifies during the luteal phase. This is driven by progesterone and is more useful as a confirmation that ovulation occurred than as a predictive sign.
Cervical position changes. During the fertile window, the cervix rises higher in the vaginal canal, becomes softer, and opens slightly (a change described as SHOW: soft, high, open, wet). After ovulation, it drops, firms, and closes. Cervical position checking is taught in some fertility awareness methods (Creighton, Billings) but requires practice to interpret accurately.
Ovulation spotting. A small percentage of women experience light spotting (a few drops of pink or brown blood) at the time of ovulation, caused by the brief estrogen dip that occurs when the egg is released. It is harmless and typically lasts only a few hours. Not to be confused with implantation bleeding, which occurs 6 to 12 days later.
Bloating and fluid retention. Estrogen promotes fluid retention, so some women notice mild bloating in the days approaching ovulation. This resolves after ovulation as progesterone counteracts the fluid-retaining effect of estrogen.
Ovulation predictor kits detect the surge in luteinizing hormone (LH) that precedes ovulation by approximately 24 to 36 hours. They are the most accessible and widely used clinical-grade ovulation detection method.
Standard OPKs (test strips or cassettes) use urine samples and produce a positive result when LH exceeds a threshold concentration (typically 25 to 40 mIU/mL). A positive result means ovulation is likely to occur within the next 24 to 36 hours. A 2017 review by Su and colleagues found that standard urinary LH tests are approximately 97% accurate at detecting the LH surge.
Digital OPKs (such as Clearblue Advanced) also measure estrogen in addition to LH, providing an earlier "high fertility" reading (when estrogen rises) before the "peak fertility" reading (when LH surges). This extends the actionable window by 1 to 2 additional days.
Best practices for using OPKs:
OPKs have some limitations. Women with PCOS often have chronically elevated LH, which can produce frequent false positives. Women with a short LH surge (under 10 hours) may miss it with once-daily testing. And OPKs confirm an LH surge, not ovulation itself — in rare cases, a surge occurs but the follicle does not rupture (luteinized unruptured follicle syndrome).
| Method | What it detects | Predicts or confirms? | Accuracy | Pros | Cons |
|---|---|---|---|---|---|
| Cervical mucus | Estrogen-driven mucus changes | Predicts (real-time) | High (Bigelow et al., 2004) | Free, daily, strong evidence base | Requires learning; subjective; affected by infections |
| OPK (standard) | LH surge | Predicts (24–36 hr lead) | ~97% surge detection | Easy to use; objective result | Cost; false positives in PCOS; can miss short surges |
| OPK (digital) | Estrogen + LH | Predicts (2–4 day lead) | ~99% surge detection | Extended fertile window; clear display | Expensive; cannot reuse readers across cycles |
| BBT | Post-ovulatory progesterone | Confirms (after the fact) | High for confirmation | Identifies anovulatory cycles; pattern analysis | Retrospective; sensitive to confounders |
| Mittelschmerz | Follicle rupture / fluid | Approximate timing | Variable; ~20% of women | No cost; no equipment | Not experienced by most women; timing imprecise |
| Wearable temp monitors | Continuous core/skin temp | Predicts + confirms | Emerging; promising | Passive tracking; less user burden | Cost; not yet validated to clinical standard |
The most effective approach for most women combines cervical mucus observation (for real-time prediction) with either OPKs (for objective confirmation of the approaching surge) or BBT (for pattern learning and anovulation detection). Using all three provides the most complete picture.
Our ovulation calculator can help you estimate your fertile window based on cycle length, and our cycle length calculator can establish your baseline pattern.
Not every menstrual cycle includes ovulation. Anovulatory cycles (cycles without ovulation) are common in specific populations and contexts:
Signs that a cycle was anovulatory include: no BBT shift throughout the entire cycle, absence of egg-white cervical mucus, no positive OPK, and either a very short or very long cycle. If anovulatory cycles occur regularly (3 or more consecutive months), evaluation for PCOS, thyroid disease, hyperprolactinemia, or hypothalamic dysfunction is appropriate.
For women actively trying to conceive, our IVF date calculator and fertility and age statistics article provide additional context on fertility planning.
The most reliable body-based sign is the change in cervical mucus to a clear, stretchy, egg-white consistency. A 2004 study in Human Reproduction found that the presence of this mucus type was a stronger predictor of conception probability than any other method. For an objective test, ovulation predictor kits (OPKs) are approximately 97% accurate at detecting the LH surge that precedes ovulation by 24 to 36 hours.
Ovulation typically occurs 12 to 16 days before the next period begins. In a 28-day cycle, this is around day 12 to 16 (counting from the first day of the last period). The luteal phase (from ovulation to the next period) is relatively consistent at 12 to 14 days, while the follicular phase (from period to ovulation) varies more. Tracking your cycles for 3 to 6 months helps identify your individual pattern.
About 20% of women experience mittelschmerz — a mild one-sided pelvic pain or twinge at the time of ovulation. It can last minutes to hours. However, most women (80%) do not feel ovulation directly. The more reliable signs are cervical mucus changes, which can be observed in the days leading up to ovulation, and LH surge detection via OPKs.
The highest probability of conception occurs with intercourse on the 1 to 2 days before ovulation, not on the day of ovulation itself (Wilcox et al., 1995, NEJM). Having intercourse every 1 to 2 days during the fertile window (5 days before through the day of ovulation) maximizes the chance of sperm being present when the egg is released. Daily intercourse is not necessary and does not significantly increase pregnancy rates over every-other-day timing.
Yes. Many women ovulate without obvious symptoms. The absence of mittelschmerz, breast tenderness, or other secondary signs does not mean ovulation is not occurring. Cervical mucus changes are often present but may be subtle if not actively monitored. BBT tracking or OPKs can detect ovulation even when no physical symptoms are noticed. If you are unsure whether you are ovulating, tracking BBT for 2 to 3 cycles will provide a clear answer.
Consistently negative OPKs can result from: testing at the wrong time of day (LH is better detected in afternoon urine), testing outside the fertile window (starting too early or too late), having a very short LH surge that is missed with once-daily testing, or not ovulating (anovulatory cycles). Try testing twice daily for one cycle. If still negative, discuss with your provider — a blood progesterone level on day 21 of the cycle can confirm whether ovulation is occurring.
Reproductive Endocrinologist
Dr. Rostova is a reproductive endocrinologist with 14 years of clinical experience specializing in ovulatory disorders, fertility preservation, and complex hormonal conditions. She has published extensively on ovulation monitoring and natural fertility awareness.
This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Nearly 80% of autoimmune disease patients are women, and the average diagnosis takes 4.6 years. Here is what the data shows about lupus, MS, Hashimoto's, and the $100 billion annual cost burden.

The 5-year survival rate for breast cancer caught early is 99%. Caught late, it drops to 31%. Here is what the latest screening, incidence, and disparity data tells us about where we stand and what still needs to change.

HPV causes 99% of cervical cancers, and the HPV vaccine reduces cervical cancer risk by 87% in vaccinated women. Here is what the latest data says about screening, vaccination rates, and the WHO's elimination target.
Join 250,000+ women receiving our weekly breakdown of new research, policy changes, and health tools. Zero fluff.